Skip to main content

Table 1 Overview of translated circRNAs and circ-proteins in carcinomas and noncarcinomas

From: Expanding uncapped translation and emerging function of circular RNA in carcinomas and noncarcinomas

Diseases

Translated circular RNAs

Circ-proteins

Ref.

CircRNAs

Length (nt)

Ribosome binding

Translation mechanism

Circ-proteins

Length (aa)

Cellular location

Sequences covering domain of host protein

Expression (Up/Down)

Function and mechanism

Carcinomas

 GBM

circE-cadherin (hsa_circ _0039992)

733

reads across BSJ in

ribosome-Seq

IRES

C-E-Cad

254

Membrane, same to E-cadherin

Unique 14-aa tail at C-termini of C-E-Cad besides shared aa 282-522 at N-terminal of E-cadherin

Up

Unique 14-aa had new function that bond to the CR2 domain of EGFR, promoted STAT3 phosphorylation and nuclear translocation to interact with EGFRvIII, inducing GBM.

[46]

 GBM

circSMO (hsa_circ _0001742)

727

In M and L polysomes fractions

IRES

SMO-193a.a

193

Cytoplasm and Membrane, same to SMO

Shared aa 230-421 at N-terminal of SMO covering most seven transmembrane domains besides one Glu at its C-termini

Up

Shared motif bond to N-terminal of SMO to translocate cholesterol, freed SMO from patched transmembrane receptors to maintain CSC self-renewal, inducing GBM.

[51]

 GBM

circEGFR (hsa_circ_0080229)

249

In M and L polysomes fractions

Rolling translation

rtEGFR

83

Membrane, same to EGFR

shared aa 561-627 across extracellular domain IV of EGFR besides unique 19 amino acids, has similar function with EGFR

Up

Shared motif bond to extracellular Domain IV of EGFR to increase EGFR stability and membrane localization, attenuating its endocytosis and degradation, inducing GBM.

[57]

 GBM

circSHPRH (hsa_circ_0001649)

440

undetected

IRES

SHPRH-146aa

146

unknown

shared aa1520–1651 covering the SNF2 domain of SHPRH besides 8-aa at its C-termini

Up

Shared motif as a decoy competitively bond to DTL to prevent its ubiquitination SHPRH which could ubiquitinate PCNA, inhibiting GBM.

[52]

 GBM

circLINC-PINT (hsa_circ_0082389)

1084

two readers across BSJ by RNC-seq

IRES

PINT87aa

87

Nucleus, same to PINT

shared amino acids at N-terminal of PINT besides 10-aa at its C-termini

Down

Bond to the domain of PAF1 as an anchor keeping PAF1 complex on target genes’ promoter to repress transcriptional elongation and GBM.

[63]

 GBM

circAKT3 (hsa_circ_0017250)

524

undetected

IRES

AKT3-174aa

174

Cytoplasm, similar to AKT3

shared aa 62-232 covering PH-domain and thr-308 of AKT3 besides 3-aa at its C-termini

Down

Shared motif bond to PDK1 to activate it, blocking AKT phosphorylation, inhibiting GBM.

[54]

 GBM

circFBXW7 (hsa_circ_022705)

620

undetected

IRES

FBXW7-185aa

185

unknown

shared 167-aa with FBXW7a besides 18-aa at its C-termini

Down

Shared motif as decoy competitively bond to USP28, releasing FBXW7a to degrade c-Myc, inhibiting GBM.

[53]

 TNBC

620

undetected

IRES

FBXW7-185aa

185

unknown

shared 167-aa with FBXW7a besides 18-aa at its C-termini

Down

Increased the abundance of FBXW7 and inducing c-Myc degradation, inhibiting TNBC.

[53]

 TNBC

circHER2 (hsa_circ_0007766)

676

In M and L polysomes fractions

IRES

HER2-103

103

Membrane, same to HER2

shared 103 amino acids at N-terminal (aa 198-300) of HER2 covering most CR I domain of HER2 for EGFR/HER3 homo/heterodimer.

Up

Bond to CR I domain of HER2, stimulated EGFR/HER3 homo/heterodimer formation, phosphorylation and activation of AKT to sensitize Pertuzumab treatment of HER-103+ TNBC.

[64]

 GC

circDIDO1 (hsa_circ_0061137)

1787

undetected

IRES

DIDO1-529aa

529

Nucleus, different from DIDO1-1a

shared 529 amino acids with NLS and PHD domain, lack of nuclear export sequence of DIDO1-1a

Down

Contrary to DIDO1-1a. bond to DNA binding domain and catalytic domain of PARP1 to block its activity, repressing GC,

[60]

 GC

circMAPK1 (hsa_circ_0004872)

490

undetected

IRES

MAPK1-109aa

109

Cytoplasm, similar to MAPK1

shared aa 98-203 covering phosphorylated sites of MAPK1 besides 3-aa at its C-termini

Down

Contrary to MAPK1, competitively bond to MEK1 to block extracellular signals to intracellular signals for MAPK phosphorylation, repressing GC.

[59]

 CC

circFNDC3B (hsa_circ_0006156)

526

undetected

IRES

circFNDC3B-218aa

218

Cytoplasm, similar to FNDC3B

shared 509 amino acids with FNDC3B besides 17-aa at its C-termini

Down

Attenuated Snail expression, enhanced FBP1-induced OXPHOS to repress CC.

[58]

 HCC

circβ-catenin (hsa_circ_0004194)

1129

undetected

IRES

β-catenin-370aa

370

Cytoplasm, similar to β-catenin

shared 361 amino acids at N-terminal of β-catenin besides 9-aa at its C-termini

Up

As a decoy binding to GSK3β to prevent it degrade β-catenin, freed β-catenin activated Wnt/β-catenin pathway, promoting HCC.

[48]

 HCC and CRC

circARHGAP35 (hsa_circ_0109744)

3867

in M polysomes fractions

m6A modification

p-circARHGAP35

1289

Nucleus, opposite to ARHGAP35

shared most amino acids at N-terminal of ARHGAP35 containing four FF domains lack of Rho GAP domain

Up

Contrary to ARHGAP35, shared motif interacted with nuclear TFII-I protein, promoting progression of HCC and CRC.

[56]

 CRC

circPPP1R12A (has_circ_0000423)

1138

undetected

undetected

circPPP1R12A-73aa

73

unknown

shared 55 amino acids besides 17-aa unique tail

Up

Activated Hippo-YAP pathway to promote CRC, which is different from PPP1R12A.

[49]

 CRC

circLgr4 (hsa_circ_02276)

unknown

undetected

undetected

circLgr4-peptide

19

Cytoplasm and nucleus

has 19-aa

Up

Interacted with extracellular domain LGR4 to activate Wnt/β-catenin pathway, promoting self-renewal and metastasis of CSC, driving CRC.

[50]

 CRC

circPLCE1 (hsa_circ_0019223)

1570

undetected

IRES

circPLCE1 411

411

Cytoplasm

shared aa 1-403 at N-terminal of PLCE1 protein with distinct function with PLCE1, besides own 8-aa tail

Down

Bond to ATP binding domain of HSP90α to accelerate RPS3 to dissociate from the HSP90α/RPS3 complex, leading to the HSP70-induced ubiquitin-dependent degradation of RPS3 and suppression of NF-κB pathway, blocking CRC.

[61]

 Bladder cancer

circGprc5a (hsa_circ_02838)

unknown

undetected

undetected

circGprc5a-peptide

11

unknown

unknown

Up

bind to Gprc5a to activate the GPCR signalling pathway and promote self-renewal and metastasis of cancer stem cells

[47]

 MM

circCHEK1 hsa_circ_0024792

738

undetected

IRES

circCHEK1_246aa

246

unknown

shared N-terminus of CHEK1, has same function with CHEK1

Up

induced Chromosomal Instability and bone lesion formation by interaction with and decrease mutant CEP170

[62]

 Cervical cancer

circE7

472

in polysomes fractions

m6A modification

E7 oncoprotein

98

Cytoplasm

Shared most amino acids with E7 protein harbouring unique sequences

Up

E7 oncoprotein is independent for the transforming activity of circE7 promoting progress of cervical cancer

[65]

Noncarcinomas

 CR

circNlgn (hsa_circ_0003046)

813

In heavy polysomes fractions

IRES

Nlgn173

173

Nucleus, different from Nlgn

9-aa tail at Nlgn173 C-termini for nuclear localization besides 164-aa at N- terminal of Nlgn

Up

Unique 9-aa motif interacts with the LaminB1 forcing nuclear localization of Nlgn173 to promote SGK3 and inhibit ING4, inducing Cardiac Remodelling, which is different Nlgn.

[66]

 AD

circAβ-a (hsa_circ_0007556)

524

undetected

IRES-like A/U-rich sequences

Aβ175

175

unknown

remaining 158-aa approaching to C-terminal of Amyloid β peptide

Up

Its expression raised in brain tissues of AD patients

[67]

 Synaptic function

circMbl

unknown

Ribosome binding

IRES-like UTR

none

unknown

Cytoplasm

unknown

Up

maybe linked to regulation of synaptic function

[45]

 DMD

circZNF609

unknown

M and L polysomes

IRES-like UTR

none

753

unknown

unknown

Up

Linked to myoblast proliferation

[38]

 Lifespan extending

circSfl

unknown

Ribosome binding

unknown

none

unknown

unknown

Sharing N-terminus with cytoplasmic and transmembrane domain

Up

extending lifespan of fruit flies

[68]

  1. ORF Open Reading Framework, BSJ back splice junction, IRES Internal Ribosome Entry Site, GBM glioblastoma, rtEGFR rolling translation EGFR, TNBC Triple-Negative Breast Cancer, GC gastric cancer, CC colon cancer, CRC colorectal carcinoma, HCC hepatocellular carcinoma, MM multiple myeloma, CR Cardiac Remodeling, AD Alzheimer’s Disease, DMD Duchenne Muscular Dystrophy, m6A, N6-methyladenosine, UTR Untranslated Region